Study suggests GLP-1 drugs may slow biological aging markers
Research referenced by UC-affiliated Nobel laureates points to GLP-1 medications, widely known for diabetes and weight-loss treatment, showing effects on biological aging indicators. The findings come from work highlighted by University of California researchers discussing discoveries made within the UC system.